论文部分内容阅读
目的:观察四磨汤口服液辅助治疗急性轻症胰腺炎患者的疗效及安全性。方法:选取100例急性轻症胰腺炎患者作为研究对象,并随机分入观察组和对照组各50例。对照组采用常规治疗,观察组在对照组治疗基础上加用四磨汤口服液进行治疗。观察比较2组患者的临床疗效、治愈时间和不良反应情况。结果:观察组临床疗效优于对照组,差异有统计学意义(P<0.05)。观察组治愈时间短于对照组,差异有统计学意义(P<0.05)。2组患者均未观察到明显的药物不良反应。结论:应用四磨汤口服液可以显著提高急性轻症胰腺炎患者的治疗效果,同时可以缩短患者的治愈时间,并且具有良好的安全性。
Objective: To observe the efficacy and safety of Simotang Oral Liquid in the treatment of acute mild pancreatitis. Methods: A total of 100 patients with acute mild pancreatitis were selected as study subjects and randomly divided into observation group (50 cases) and control group (50 cases). The control group was treated with conventional treatment. The observation group was treated with Siu Tang Decoction on the basis of the control group. The clinical efficacy, cure time and adverse reactions of two groups were observed and compared. Results: The clinical efficacy of the observation group was better than that of the control group, the difference was statistically significant (P <0.05). The cure time of the observation group was shorter than that of the control group, the difference was statistically significant (P <0.05). No significant adverse drug reactions were observed in both groups. Conclusion: The application of Siwutang Oral Liquid can significantly improve the treatment of patients with acute mild pancreatitis, while reducing the patient’s healing time, and has good safety.